Effects of lasofoxifene and bazedoxifene on b cell development and function

Immunity, Inflammation and Disease

Volumn 2, Issue 4, 2014, Pages 214-225

  Bernardi, Angelina I ^a   Andersson, Annica ^a   Grahnemo, Louise ^a   Nurkkala Karlsson, Merja ^a   Ohlsson, Claes ^a   Carlsten, Hans ^a   Islander, Ulrika ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Antibody production; B cell development; Estrogen; Mouse; SERMs

Indexed keywords

EID: 84979020414     PISSN: None     EISSN: 20504527     Source Type: Journal    
DOI: 10.1002/iid3.37     Document Type: Article

References (45)

1. Sowers, M. R., and M. T. LaPietra. 1995. Menopause: its epidemiology and potential association with chronic diseases. Epidemiol. Rev. 17:287–302.
2. Barrett-Connor, E., and D. Grady. 1998. Hormone replacement therapy, heart disease, and other considerations. Annu. Rev. Publ. Health 19:55–72.
3. Hadji, P. 2012. The evolution of selective estrogen receptor modulators in osteoporosis therapy. Climacteric 15:513–523.
4. Masuzawa, T., C. Miyaura, Y. Onoe, K. Kusano, H. Ohta, S. Nozawa, et al. 1994. Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J. Clin. Invest. 94: 1090–1097.
5. Medina, K. L., and P. W. Kincade. 1994. Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. Proc. Natl. Acad. Sci. USA 91:5382–5386.
6. Smithson, G., K. Medina, I. Ponting, and P. W. Kincade. 1995. Estrogen suppresses stromal cell-dependent lymphopoiesis in culture. J. Immunol. 155:3409–3417.
7. Medina, K. L., G. Smithson, and P. W. Kincade. 1993. Suppression of B lymphopoiesis during normal pregnancy. J. Exp. Med. 178:1507–1515.
8. Nilsson, N., and H. Carlsten. 1994. Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation. Cell Immunol. 158:131– 139.
9. Erlandsson, M. C., C. A. Jonsson, M. K. Lindberg, C. Ohlsson, and H. Carlsten. 2002. Raloxifene-and estradiol-mediated effects on uterus, bone and B lymphocytes in mice. J. Endocrinol. 175:319–327.
10. von Freeden-Jeffry, U., P. Vieira, L. A. Lucian, T. McNeil, S. E. Burdach, and R. Murray. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1519–1526.
11. Rolink, A., U. Grawunder, T. H. Winkler, H. Karasuyama, and F. Melchers. 1994. IL-2 receptor alpha chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int. Immunol. 6:1257–1264.
12. Medina, K. L., A. Strasser, and P. W. Kincade. 2000. Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood 95:2059–2067.
13. Casola, S. 2007. Control of peripheral B-cell development. Curr. Opin. Immunol. 19:143–149.
14. Batten, M., J. Groom, T. G. Cachero, F. Qian, P. Schneider, J. Tschopp, et al. 2000. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192:1453–1466.
15. Harless, S. M., V. M. Lentz, A. P. Sah, B. L. Hsu, K. Clise-Dwyer, D. M. Hilbert, et al. 2001. Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers. Curr. Biol. 11:1986–1989.
16. Grimaldi, C. M., D. J. Michael, and B. Diamond. 2001. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J. Immunol. 167:1886–1890.
17. Hill, L., V. Jeganathan, P. Chinnasamy, C. Grimaldi, and B. Diamond. 2011. Differential roles of estrogen receptors alpha and beta in control of B-cell maturation and selection. Mol. Med. 17:211–220.
18. Smith, K. G., T. D. Hewitson, G. J. Nossal, and D. M. Tarlinton. 1996. The phenotype and fate of the antibody-forming cells of the splenic foci. Eur. J. Immunol. 26:444–448.
19. McHeyzer-Williams, L. J., D. J. Driver, and M. G. McHeyzer-Williams. 2001. Germinal center reaction. Curr. Opin. Hematol. 8:52–59.
20. Offner, H., K. Adlard, A. Zamora, and A. A. Vandenbark. 2000. Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis. J. Clin. Invest. 105:1465–1472.
21. Reagan-Shaw, S., M. Nihal, and N. Ahmad. 2008. Dose translation from animal to human studies revisited. FASEB J. 22:659–661.
22. Tarkowski, A., C. Czerkinsky, L. A. Nilsson, H. Nygren, and O. Ouchterlony. 1984. Solid-phase enzyme-linked immuno-spot (ELISPOT) assay for enumeration of IgG rheumatoid factor-secreting cells. J. Immunol. Methods 72:451–459.
23. Windahl, S. H., O. Vidal, G. Andersson, J. A. Gustafsson, and C. Ohlsson. 1999. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta( / ) mice. J. Clin. Invest. 104:895–901.
24. Clark, M. R., M. Mandal, K. Ochiai, and H. Singh. 2014. Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling. Nat. Rev. Immunol. 14:69–80.
25. Osmond, D. G., A. Rolink, and F. Melchers. 1998. Murine B lymphopoiesis: towards a unified model. Immunol. Today 19:65–68.
26. Dal Porto, J. M., S. B. Gauld, K. T. Merrell, D. Mills, A. E. Pugh-Bernard, and J. Cambier. 2004. B cell antigen receptor signaling 101. Mol. Immunol. 41:599–613.
27. Lesley, R., Y. Xu, S. L. Kalled, D. M. Hess, S. R. Schwab, H. B. Shu, et al. 2004. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 20:441–453.
28. Peeva, E., J. Venkatesh, and B. Diamond. 2005. Tamoxifen blocks estrogen-induced B cell maturation but not survival. J. Immunol. 175:1415–1423.
29. Grimaldi, C. M., J. Cleary, A. S. Dagtas, D. Moussai, and B. Diamond. 2002. Estrogen alters thresholds for B cell apoptosis and activation. J. Clin. Invest. 109:1625–1633.
30. Bynoe, M. S., C. M. Grimaldi, and B. Diamond. 2000. Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc. Natl. Acad. Sci. USA 97:2703–2708.
31. Islander, U., M. C. Erlandsson, B. Hasseus, C. A. Jonsson, C. Ohlsson, J. A. Gustafsson, et al. 2003. Influence of oestrogen receptor alpha and beta on the immune system in aged female mice. Immunology 110:149–157.
32. Erlandsson, M. C., C. A. Jonsson, U. Islander, C. Ohlsson, and H. Carlsten. 2003. Oestrogen receptor specificity in oestra-diol-mediated effects on B lymphopoiesis and immunoglob-ulin production in male mice. Immunology 108:346–351.
33. Gennari, L. 2006. Lasofoxifene: a new type of selective estrogen receptor modulator for the treatment of osteoporosis. Drugs Today (Barc) 42:355–367.
34. Komm, B. S., Y. P. Kharode, P. V. Bodine, H. A. Harris, C. P. Miller, and C. R. Lyttle. 2005. Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity. Endocrinology 146:3999–4008.
35. D’Elia, H. F., A. Larsen, L. A. Mattsson, E. Waltbrand, G. Kvist, D. Mellstrom, et al. 2003. Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis. J. Rheumatol. 30:1456– 1463.
36. Holmdahl, R., L. Jansson, and M. Andersson. 1986. Female sex hormones suppress development of collagen-induced arthritis in mice. Arthritis Rheum. 29:1501–1509.
37. Jochems, C., U. Islander, M. Erlandsson, C. Engdahl, M. Lagerquist, C. Ohlsson, et al. 2011. Effects of oestradiol and raloxifene on the induction and effector phases of experimental postmenopausal arthritis and secondary osteoporosis. Clin. Exp. Immunol. 165:121–129.
38. Ostensen, M. 1999. Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Ann. NY Acad. Sci. 876:131–143; discussion 44.
39. Jochems, C., U. Islander, A. Kallkopf, M. Lagerquist, C. Ohlsson, and H. Carlsten. 2007. Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis. Arthritis Rheum. 56:3261–3270.
40. Gompel, A., and J. C. Piette. 2007. Systemic lupus erythematosus and hormone replacement therapy. Menopause Int. 13:65–70.
41. Roubinian, J. R., N. Talal, J. S. Greenspan, J. R. Goodman, and P. K. Siiteri. 1978. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J. Exp. Med. 147:1568–1583.
42. Carlsten, H., N. Nilsson, R. Jonsson, K. Backman, R. Holmdahl, and A. Tarkowski. 1992. Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell Immunol. 144:190–202.
43. Grimaldi, C. M., V. Jeganathan, and B. Diamond. 2006. Hormonal regulation of B cell development: 17 beta-estradiol impairs negative selection of high-affinity DNA-reactive B cells at more than one developmental checkpoint. J. Immunol. 176:2703–2710.
44. Zhang, Y., S. Saha, G. Rosenfeld, J. Gonzalez, K. P. Pepeljugoski, and E. Peeva. 2010. Raloxifene modulates estrogen-mediated B cell autoreactivity in NZB/W F1 mice. J. Rheumatol. 37:1646–1657.
45. Mok, C. C., S. K. Ying, K. M. Ma, and C. K. Wong. 2013. Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trial. Lupus 22:1470–1478.